164 related articles for article (PubMed ID: 28202352)
1. Amino acid transporter SLC38A3 promotes metastasis of non-small cell lung cancer cells by activating PDK1.
Wang Y; Fu L; Cui M; Wang Y; Xu Y; Li M; Mi J
Cancer Lett; 2017 May; 393():8-15. PubMed ID: 28202352
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
3. Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.
Chen M; Hu C; Guo Y; Jiang R; Jiang H; Zhou Y; Fu H; Wu M; Zhang X
Oncol Rep; 2018 Sep; 40(3):1339-1347. PubMed ID: 29956803
[TBL] [Abstract][Full Text] [Related]
4. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
Wang B; Tang Z; Gong H; Zhu L; Liu X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
[TBL] [Abstract][Full Text] [Related]
5. [CK2α Regulates the Metastases and Migration of Lung Adenocarcinoma
A549 Cell Line through PI3K/Akt/GSK-3β Signal Pathway].
Wu A; Li M; Mai Z; Li S; Yang Z
Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):233-238. PubMed ID: 28442011
[TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
7. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
8. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
Zeng C; Wu Q; Wang J; Yao B; Ma L; Yang Z; Li J; Liu B
Free Radic Biol Med; 2016 Dec; 101():236-248. PubMed ID: 27989748
[TBL] [Abstract][Full Text] [Related]
9. miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells.
Ye XW; Yu H; Jin YK; Jing XT; Xu M; Wan ZF; Zhang XY
Clin Respir J; 2015 Jan; 9(1):27-33. PubMed ID: 24405893
[TBL] [Abstract][Full Text] [Related]
10. miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.
Li X; Han J; Zhu H; Peng L; Chen Z
Int J Oncol; 2017 Jul; 51(1):158-168. PubMed ID: 28534939
[TBL] [Abstract][Full Text] [Related]
11. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
[TBL] [Abstract][Full Text] [Related]
13. TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway.
Zhang S; Dai H; Li W; Wang R; Wu H; Shen M; Hu Y; Xie L; Xing Y
Cell Death Dis; 2021 Nov; 12(12):1086. PubMed ID: 34789718
[TBL] [Abstract][Full Text] [Related]
14. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
15. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
[TBL] [Abstract][Full Text] [Related]
16. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-κB.
Liu W; Wang H; Bai F; Ding L; Huang Y; Lu C; Chen S; Li C; Yue X; Liang X; Ma C; Xu L; Gao L
Cell Prolif; 2020 Mar; 53(3):e12776. PubMed ID: 32020709
[TBL] [Abstract][Full Text] [Related]
17. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Kwon OS; Oh E; Park JR; Lee JS; Bae GY; Koo JH; Kim H; Choi YL; Choi YS; Kim J; Cha HJ
Oncotarget; 2015 Dec; 6(39):41916-28. PubMed ID: 26544896
[TBL] [Abstract][Full Text] [Related]
18. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
[TBL] [Abstract][Full Text] [Related]
19. YXQ-EQ Induces Apoptosis and Inhibits Signaling Pathways Important for Metastasis in Non-Small Cell Lung Carcinoma Cells.
Yan X; Shen H; Jiang H; Hu D; Wang J; Wu X
Cell Physiol Biochem; 2018; 49(3):911-919. PubMed ID: 30184531
[TBL] [Abstract][Full Text] [Related]
20. Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Zhang W; Shao X
Med Sci Monit; 2016 Nov; 22():4644-4650. PubMed ID: 27897153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
